47% of all dogs over the age of 10 will die from cancer. With current treatment options expensive and potentially leading to negative side effects, Torigen is focused on commercializing, VetiVax, a novel, personalized immunotherapy that uses the animals’ own tumor cells to fight the cancer.

Using a surgically excised portion of tumor tissue, we create a series of treatments that are given back to the animal to help stimulate their immune system to fight cancer, safely and inexpensively.

2017
2017  Finalist